
Female Urology
Latest News
Advertisement
Latest Videos

Shorts

0:30
Correcting misconceptions about hormone therapy for GSM
a month ago
by
Engy Habashy, MD

0:46
Testosterone therapy in women: Rethinking pre- and postmenopausal categories
3 months ago
by
Jessica M. Yih, MD

0:22
Catherine A. Matthews, MD, FACS, on the U-POP & LUTD 2026 Global Consensus Conference
6 months ago
by
Catherine A. Matthews, MD, FACOG, FACS, FPMRS

0:44
Savitha Krishnan, MD, on signs of prolapse urologists should watch for
6 months ago
by
Savitha Krishnan, MD

1:15
Melissa Moran, DO, on prescribing patterns for postmenopausal female HSDD
9 months ago
by
Melissa Moran, DO

1:00
Aleece Fosnight, MSPAS, PA-C, on how vaginal estrogen cream helps patients
10 months ago
by
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

1:09
Aleece Fosnight, MSPAS, PA-C, on hydration and pelvic floor physical therapy for bladder symptoms
10 months ago
by
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

0:53
Aleece Fosnight, MSPAS, PA-C, on evaluating cyclical bladder symptoms in women
10 months ago
by
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

1:05
Aleece Fosnight, MSPAS, PA-C, on hormonally mediated bladder symptoms and IC/BPS
10 months ago
by
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

1:13
Aleece Fosnight, MSPAS, PA-C, on why progesterone affects your bladder during your cycle
a year ago
by
Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES
Podcasts
CME Content
Advertisement
More News

2025 featured multiple advancements in women's health aimed at enhancing treatment options and awareness.

As the year comes to a close, we revisit some of this year’s top content in female urology.

Sameena A. Rahman, MD, said she sees this development as a hopeful signal amid a challenging landscape for women’s health care.

With this approval, flibanserin becomes the first and only treatment of its kind for women younger than 65 years.

Daré Bioscience said the sildenafil cream’s availability will expand to other states throughout December 2025 and early 2026.

Sameena A. Rahman, MD, said she anticipates that the regulatory stance may encourage more clinicians to adopt a layered therapeutic approach for patients with severe GSM.
Advertisement
Advertisement
Trending on Urology Times
1
Rethinking Testosterone Therapy After the FDA Label Revisions
2
FDA clears phase 1/2 trial of androgen receptor antagonist in mCRPC
3
BPH treatment patterns: Understanding regional differences in baseline ED treatment
4
Gedatolisib plus darolutamide: Early findings in mCRPC
5






















